BioSenic S.A. (BIOS.BR)
ValueMarkers Composite Index
DCF data not available
BioSenic S.A. (BIOS.BR) — VMCI valuation read
Composite valuation read on BIOS.BR: VMCI 37/100 against a Healthcare sector median of 50. The 13-point below-median print is the headline number for BioSenic S.A., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.
Trailing 30-day insider activity for BIOS.BR: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.
**Investor frame.** Value, quality, risk in three lines on BIOS.BR: BIOS.BR trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp; net debt to EBITDA of -0.2x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.
BIOS.BR fell 0.6% over the trailing 7 days, with a -21.4% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.